US Patent Issued to Reverb Therapeutics on June 30 for "Cytokine-based therapies and methods" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,627, issued on June 30, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada).

"Cytokine-based therapies and methods" was invented by David De Graaf (Vancouver, Canada), Mark Fogg (Vancouver, Canada), Surjit Bhimarao Dixit (Vancouver, Canada) and Stacey Tom-Yew (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods for redirecting an active form of an endogenous cytokine to a target cell or target tissue of interest in a biological system or subject in need thereof by administering a multi-specific binding molecule comprising (a) a binding domain that specifically binds to an active form of a cytok...